1. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling
- Author
-
Frédéric Colland, Kei-ichiro Arimoto, Ming Yan, Dong-Er Zhang, Sandra Pellegrini, Stephan Wilmes, Yue Zhang, Jacob Piehler, Samuel A Stoner, Sayuri Miyauchi, Jürgen J. Heinisch, Sara Löchte, Christoph Burkart, Zhi Li, Jun-Bao Fan, University of California [San Diego] (UC San Diego), University of California, Fachhochschule Osnabrück, Signalisation des Cytokines - Cytokine Signaling, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Hybrigenics [Paris], Hybrigenics, This study was supported by NIH R01HL091549 and R01CA177305 to D.-E.Z. and SFB 944 from the DFG to J.P. and J.J.H., University of California (UC), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Li, Zhi
- Subjects
0301 basic medicine ,MESH: Signal Transduction ,MESH: Interferon Type I ,MESH: Feedback, Physiological ,Receptor, Interferon alpha-beta ,Medical and Health Sciences ,Interferon alpha-beta ,MESH: Mutant Proteins ,Mice ,0302 clinical medicine ,Structural Biology ,Interferon ,MESH: STAT2 Transcription Factor ,MESH: Animals ,STAT2 ,Receptor ,MESH: Endopeptidases ,Feedback, Physiological ,Tumor ,biology ,MESH: Immunoblotting ,Effector ,Biological Sciences ,3. Good health ,Cell biology ,030220 oncology & carcinogenesis ,Interferon Type I ,MESH: Protein Domains ,Signal transduction ,Ubiquitin Thiolesterase ,medicine.drug ,Protein Binding ,Signal Transduction ,Cell signaling ,MESH: Cell Line, Tumor ,Physiological ,Immunoblotting ,Biophysics ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,MESH: Two-Hybrid System Techniques ,Article ,Cell Line ,Feedback ,03 medical and health sciences ,Immune system ,Protein Domains ,Cell Line, Tumor ,Two-Hybrid System Techniques ,Endopeptidases ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,medicine ,MESH: Protein Binding ,MESH: Receptor, Interferon alpha-beta ,Animals ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,[SDV.BC] Life Sciences [q-bio]/Cellular Biology ,Molecular Biology ,MESH: Mice ,MESH: Humans ,STAT2 Transcription Factor ,030104 developmental biology ,Chemical Sciences ,Cancer research ,biology.protein ,Mutant Proteins ,Interferon type I ,Developmental Biology - Abstract
International audience; Type I interferons (IFNs) are multifunctional cytokines that regulate immune responses and cellular functions but also can have detrimental effects on human health. A tight regulatory network therefore controls IFN signaling, which in turn may interfere with medical interventions. The JAK-STAT signaling pathway transmits the IFN extracellular signal to the nucleus, thus resulting in alterations in gene expression. STAT2 is a well-known essential and specific positive effector of type I IFN signaling. Here, we report that STAT2 is also a previously unrecognized, crucial component of the USP18-mediated negative-feedback control in both human and mouse cells. We found that STAT2 recruits USP18 to the type I IFN receptor subunit IFNAR2 via its constitutive membrane-distal STAT2-binding site. This mechanistic coupling of effector and negative-feedback functions of STAT2 may provide novel strategies for treatment of IFN-signaling-related human diseases.
- Published
- 2017